A carregar...
The Role of Targeted Agents in the Treatment of Metastatic Breast Cancer
To date, blockade of growth factor receptors is the mainstay of targeted therapy in metastatic breast cancer (mBC). Monoclonal antibodies such as trastuzumab and bevacizumab represent the first generation of molecular-based therapies. Both the HER2 inhibitors and the vascular endothelial growth fact...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger GmbH
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931051/ https://ncbi.nlm.nih.gov/pubmed/20847826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000314996 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|